Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol.... Wake me up when the games are over and we are above .03. If you get shaken on the first red day despite having support where it needs to be, then thanks for the shares.
Great find!!! Expanding to Europe!! I like it.
Strong hands here! I love it!
Love the initiative. Would love to get some information about new contracts and customers!
Accumulating. Down slightly but its holding pretty well for such high sell pressure. 20mm in volume and price is holding even.
Added another 100k at .02
I also honestly wouldn't be surprised if this transaction gets revised to be more favorable for us... Selling shares for .04 and .08 were a great deal a week ago. Now that the market finally caught on to it, that isn't going to be in line with market prices at all. I legitimately wouldn't be surprised to see a revised offer and/or a third-party coming to try to buy the company out.
Everything is already in place for a massive P.E. fund, hedge fund, or strategic operator to come in, take this over and grow it exponentially. Not that current management can't, but it doesn't hurt to have a well known strategic or PE fund in your corner.
Read the article posted in comment # 3396 posted by Dino.
Not only do they have the Carson City hospital they just finished, they have a they extended their relationship with MS children's hospital for 3 years (recurring, stable revenue for 3 years) PLUS MS has voiced interest in integrating PCT's tech into all 10 of the hospitals associated with the MS group.....
This company has been operating for one full quarter.... I was hesitant to invest more. This is legitimately about to fly IMO. And I know I sound over excited, but this is exciting. This is so scalable. They have the right model going with sales reps to do the heavy sales lifting so that managment can continue to focus on building out a quality corporation.
Posted April 29:
https://www.linkedin.com/pulse/pct-health-completes-implementation-control-system-carson-jody-read/
This hospital purchased what looks to be the most expansive system that PCT has installed to date. Can only imagine this bodes well for revenues.
Man, this thing is a train. Kudos folks. Glad to be here with everyone.
Waiting on funds to wire to TD. Going to load another 200k and average up some.
When is the Morningstar price target report coming out. $Shmp got one. This one deserves one too.
Agreed on your approach to the value. Only thing I would add is that they do already have some sales. And they have a few repeat customers which provides supports the fact that their product has some value.
Some information about Ron:
https://midasletter.com/2018/02/video-current-water-technologies-using-patents-clean-public-water-around-world/
Talk about synergies.... This is shaping up to be a massive roll-up between Pumptronics, Current Water Tech, and PCT. All three companies deal with water technology and deal with the same clients. Ron states (interview is slightly dated) that 2018 revenue for Pumptronics should come in around $13mm. Together the three companies can provide complimentary services and open PCT to existing customer relationships.
Also per Ron's Linkedin:
"Ron also acquired the controlling block of a TSX listed company called C.A. Bancorp in 2010, and completed the plan of arrangement which injected over $70m in capital into Partners REIT ( PAR.UN- TSX listed). Ron sold his interest in 2014, after building the Partners REIT, a TSX company from $110m to over $600m in assets."
Any person that can acquire controlling blocks of a bank and grow a companies assets by 6x is somebody I want to partner with....
Bring on Tuesday.
Per that interview, their market cap was 19mm. This was at a time when they had (1) less sales; (2) a less proven technology as evidenced by their now increased sales; (3) a less expansive sales force; and (4) due to the conversions, the company is now free of a significant portion of toxic debt.
19mm market cap = $0.19
The more research I do, the more excited I get about this company.
The hospital cleaning services industry is extremely fragmented. There is not a single major player from my understanding, and it seems like most hospitals and medical offices contract out. Most of the companies providing these services are using traditional methods. Since the prevalence of hospital infections is rising, clearly these methods are not very effective.
Additionally, with the aging population, you are going to have more hospital visits which in turn entails more risk for infections spreading and thus more need for thorough cleanings.
And the hospital portion is just one stream of revenue. They also can sell to schools, food processors (which they have already), hotels, restaurants, and oddly the oil and gas industry. The R/M here is great and all, but I would have invested in this Co. with or without the R/M. R/M simply brought attention to a company that fell through the cracks.
For reference as well (and all IMO), I figured I would place some near terms price targets... Revenue for TTM is going to be north of $400k. To be conservative, I am going to assume a 3x revenue multiplier (highly underestimated). On that basis, PPS would be (400k * 3)/(106mm shares outstanding). That gives us roughly .012 which is what the price is today (I commend the market for accurately pricing an OTC play for once). What that valuation misses however is the substantial growth that this company could achieve. In fact, it barely assumes any growth at all. If you assume even twice the annual sales (likely to occur this year) and a more realistic revenue multiple for what these types of OTC plays generally demand, buying shares now and holding could result in a substantial payday.
Most of the notes can be viewed as exhibits to the 10-K and are also summarized within the 10-K. Most of the notes limit the amount of shares the note holders can hold at one time to 4.99% of total outstanding shares. So sure, the holders could convert, sell, and repeat such that they never hold more than 4.99% of the shares. But that doesn't happen overnight. And as this price gets pushed up, their conversion rates are drastically affected.
So yes, some conversions may be happening (I can't say for sure). But at the same time, end of day drop on Friday was not due to dilution or anything like that. There were plenty of major ask slaps. It was the pro traders refusing to chase and weak hands panic selling down that was the issue. Hope that continues happening. I'll keep on loading.
Sounds like more sales and distribution agreements are to come. This company has it all going with regards to a monster OTC play. They have a proven product (evidenced by repeat sales and growing sales), revenue that is not only recurring (license and product revenue) but also that is not industry dependent.
If the company is smart, they will release additional news this week. If so, hold on tight.
10-K Info (Copy and Pasted):
PCT LTD’s wholly-owned operating subsidiary, PCT Corp., is a technology development, design, and manufacturing company specializing in providing cleaning/sanitizing/disinfectant equipment that creates environmentally safe solutions for global sustainability. PCT Corp. markets new products and technologies for the Healthcare, Agriculture, and Oil & Gas industries through multi-year system and service contracts that provide equipment and support for our customers.
The Company holds patents, trademarks, intellectual property and distribution rights to our innovative products and technologies. While a direct-sales capability is in place and will be expanded, it is not PCT Corp.’s intent to be the sole distributor of our technology products. In addition to the direct sales program, senior management is responsible for continuing to develop the distribution and licensing program operations for the technology; to develop new opportunities and applications for the products, and to promote the brands. Paradigm’s senior management intends to also continue the pursuit of new technologies – particularly technologies which are complementary to or enhance applications opportunities for its existing products - upon which it will build and expand its business.
Paradigm has developed several commercially-ready product generator systems for Hydrolyte ® , an EPA registered, highly effective sanitizer/disinfectant microbiocide that is safe and non-toxic for use around humans and animals. Hydrolyte ® has been market tested with commercial customers is ready for and is involved in the initial stage of full-scale commercial launch. Management intends to focus on leveraging the opportunities presented by Hydrolyte ® in the short term and is in the first stage of a full commercial launch, commencing now, in the first half of 2018.
Paradigm’s revenue stream is expected to be derived primarily from service contracts and equipment leasing and sales as well as licensing and distributor agreements. In the 2017 “soft” launch, management focused on establishing distributor operations and direct sales in addition to expanding its production capabilities. Initially, direct sales are being managed by members of the senior management team. Subsequently, direct sales may be conducted by a subsidiary company(s) with existing customer relationships and targeted marketing and sales operations. Paradigm has finalized agreements with four distributors and is in negotiations with three additional distributors who are preparing to undertake commercial operations in their respective regional markets. The existing distributors are based in New Jersey/New York, North Carolina, Ohio, and Florida. Management expects to add more distributors throughout the year and in in negotiations with several potential distributors for certain market segments including regional markets in the southeastern portion of the U.S., Texas, mid-Atlantic region and the Caribbean.
In building out its production capabilities, Paradigm has developed strategic operating relationships with firms that are leaders in production, manufacturing, and distributions within the various industries where the markets for our technologies exist. Management believes that this strategy, properly executed, should allow for the most rapid possible rollout of the products and solid capture of market share.
And for the record, Morgan Stanley's Children Hospital is the affiliated hospital with Colombia University... These aren't dumb people who are repeat customers. In fact, they are some of the smartest doctors and business people around.
I see this going to at least .15+ in all honesty. Everybody is talking about the merger as if it is the major news (its good news for sure) but is leaving out the fact that this technology is patented and they have REAL sales. Sure it's only 200k. But that is huge considering it was only their first full quarter operating. Judging from the press releases, they have repeat customers which is a testament to the quality and usefulness of their product. Since their product is useful for several major industries, I expect sales to continue growing.
In February this company was trading in the low .30s and .20s. Since that time they announced repeat customers, additional deals, and now have a better capital structure with international expansion.... Not to mention, there are lock-up agreements being signed which bodes well for all of us as blind shareholders.
As with many other rapid rises, this will generate significant attention for them. I'm assuming more deals and success will come from this new attention.
Naturally, these are my opinions. But this is definitely more than just your average OTC scam situation.
Just volume the way to play it. Glad to be here with you!
450mm is not correct. Authorized Shares only 300mm. Float likely around 70-80mm per OTC website.
Thin as hell back up. Holding for higher before I take some profit to build a nice base.
anybody have any suggestions on a real time candlestick ticker. TD ameritrade's platform used to have a good one but its trash now.
Thats only part of it. The company retiring a ton of toxic debt. They are also recapitalizing to grow (likely inventory). The company was greatly oversold and has a patented envionrmentally friendly tech that is getting notice by hospitals. The news just finally put this on the radar.
If this company is smart, they will put out news Monday morning. Shit will BOOM even more.
Yes.... This will gap up monday.
One reason I think this will continue to really run, is that it is a legit tech. Like eradicating diseases is going to be huge. These units are easy to install and kill bacteria in an environmentally friendly way. This co. has real revenues, real patented tech, and real growth....
Not even going to lie, I took a sizeable position in this yesterday.... I got so lucky even coming across this. Found it at 2am the other night running a random stock screener after watching a Tim Sykes video. Seemed like a supernova set up. Can't believe news hit last night.
Anybody who was short to start the day and hasn't gotten out is going to get absolutely roasted. Hope to see a massive short squeeze into the weekend. News will spread of CO and Monday will be a gap up.
If there is anybody short on this, they are sweating bullets currently.
DD INSIGHTS FROM 8K
I noticed in the 8K that the signatory for the acquirer was Ronald Hrynyk. I glanced over his Linkedin and found that he has some nice successes in strategic M&A situations. He also has grown companies himself and sold them, which means he like has a stable financial backing.
The most interesting thing I noticed was that Ron was an investor in ANB Canada, which does about $83mm a year in sales and its description notes that it operates in the OTC healthcare space (seems like fitting experience and connections. He also has some serious experience fundraising, which is helpful.
The third thing I saw in the 8k that was interesting is that the acquirer will have sole rights to sell the products into Canada. This is also interesting as, it tips me to think that there may already be a customer lined up because why else expand to Canada... There is plenty of Pink Sheet money in the states.
When researching Jody Read (CEO), I found that he also has extremely relevant experience. He started a medical sales and healthcare business services company (CSA LLC) and grew it to $40mm a year in sales which got it recognized by Forbes for being one of the fastest emerging companies in the US. Again, extremely relevant experience.
This company almost matched its entire 2018 revenue, in Q1 ($195k Q1 v $250ish 10K 18). Mind you, this is really their first quarter of seriously operating (They didn't commercialize fully until Nov. 2018). In 3 months, they grew their sales a ton and have inked several deals. They can diversify by offering non hospitals goods which opens their line of revenue nicely. If they continue to ink deals and sales continue to grow, they could do $1mm in sales this year (mind you the current mkt cap is like $300k). Not saying they will, but with an operational product that has patents and that solves some major issues, I think growth will continue.
Lastly, a substantial portion of the money is going to working cap (not to mention current toxic debt being replaced for more favorable debt with higher conversion rates). In March 19, the company had a significant portion of A/R. This tells me several things, (1) usually when A/R grows that means sales are growing; (2) it tells me that they also need more money than what their significant A/R is going to yield which generally means some sort of expenditure. I'm hoping that this money goes towards inventory so that they can ramp up and scale.
Very interesting setup here.
Agreed. Waiting for $GEVI news to hit. I may liquidate some of my position there to redirect here. I mean this is actually ridiculous. Mkt cap is 1x sales..... for a company that is signing deals and has a patented technology that solves a major problem.... once people catch on, your 1.8mm shares will be worth a ton.
Hope to see more games being played. Will continue to accumulate and wait. I did see that PCTL signed an LOI to sell to another Co. ( I hope that fails as I believe this Co. has potential on its own) Even if that news hits, we should make substantial money.
For some reason this has an $SHMP feel to it. Share structure is more favorable here. The product is less revolutionary but it still solves a major problem from my understanding. And, the most important fact of them all, unlike SHMP, this company is already generating real revenues. In Q1, they did more sales than all of last year. If that trend continues to hold, we could see a major run up.
Picked up 200k+ shares today. If this thing can break .004s or .005s I think well be off to the races, IMO.
I was impressed with how it held today. I figured there was going to be people banking profits after the week we had. There were definitely more sellers on the day, but nobody was rushing to sell even as the price fell today. There seems to be a strong appetite for .05s+. With the new hire, the industry, and the small share structure, I'm starting to think we could see more than .20s or .30s.
There's CBD companies out there with substantially less promise that are trading for much higher multiples. If $GEVI puts out some good press with filings I think people will flock.
Just my opinion.
$GEVI Strong!
$GEVI. Float is low (somewhere between 12mm and 22mm). R/M play that has not made much noise up to this point. CBD company that has been operating for 4+ years. Recently acquired 350 acres and already have 10 greenhouses being constructed to grow hemp. Management recently sat down with Rhett Jordan who is one of the founders of Native Roots which is the largest dispensary group in CO.
On sub 1mm volume days, the price has skyrocketed. Was trading mid .02s end of last week and closed at .051 today. Go check the chart. Very thin to .20s.
https://closeup360.com/business/bobby-portis-new-york-knicks-nba-free-agency/
Seems like Bobby Portis may be getting his own flavor (pralines and cream) as well, based on this article. Assuming he is not the undisclosed celebrity, that would make three celebrity partnerships.
Simply speculation here, but it falls in line with how many of $NGTF's partnerships have been made.
Tweet today from Sean Folkson:
Today we begin development on our SECOND Nightfood celebrity flavor. What a fun way to introduce MILLIONS to our award-winning brand!#stockup #2019productoftheyear #icecream #otcqb #otcmarkets #ngtf
— Sean Folkson (@seanfolkson) July 3, 2019
Sold some at .026 today just in case it drops again and I can pick up more shares. Always hate selling the bid but still holding a substantial position here. Looking forward to filings.